InvestorsHub Logo
Followers 95
Posts 7790
Boards Moderated 1
Alias Born 06/17/2008

Re: boston127 post# 2513

Thursday, 08/26/2021 11:31:10 PM

Thursday, August 26, 2021 11:31:10 PM

Post# of 2720
Mick: any thoughts on today's jump?

I'm hoping that the recent volume, and today's jump, is that the FDA has responded and their application will be approved.

In June, we submitted an updated 510(k) summary to the FDA for our Acuitas AMR Gene Panel for isolates. The FDA had previously provided substantive feedback on what we believe is all key documents, including the package insert, electronic user guide and operator manual, in line with their currently expected timeline of doing so by the end of May. The FDA recently reiterated to us that it intends to complete its review by the end of August of 2021.

Since submitting our revised documents to the FDA, we have not received any additional feedback nor questions or requests for additional information. Although the FDA clarified that their timelines can be affected by various factors, we're confident in the progress moving us much closer towards reaching a final FDA clearance decision point in the coming weeks based on the FDA's current expected timeline.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPGN News